D
Viridian Therapeutics, Inc. VRDN
$11.63 -$1.02-8.06%
Recommendation
Sell
Prev Close
$12.65
Volume
566,880
Avg Vol (90D)
1,166,550
Market Cap
$1.03B
Dividend & Yield
--
52-Week Range
$11.40 - $27.20
P/E (TTM)
--
EPS (TTM)
-$3.20
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Viridian Therapeutics (VRDN, $12.65) RSI Indicator left the oversold zone on April 03, 2025
4/4/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $13.07) RSI Indicator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
25,000 Shares in Viridian Therapeutics, Inc. (NASDAQ:VRDN) Bought by Knott David M Jr
4/2/2025 - MarketBeat
Pictet Asset Management Holding SA Boosts Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN)
4/2/2025 - MarketBeat
Viridian Therapeutics (VRDN, $13.48) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $13.48) price may climb as it broke lower Bollinger Band on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Loomis Sayles & Co. L P Acquires New Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN)
3/29/2025 - MarketBeat
BIT Capital GmbH Increases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)
3/28/2025 - MarketBeat
Viridian Therapeutics (VRDN, $14.16) price may climb as it broke lower Bollinger Band on Mar 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Viridian Therapeutics (VRDN, $14.16) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Rating of "Moderate Buy" by Analysts
3/27/2025 - Ticker Report
Raymond James Financial Inc. Makes New $6.02 Million Investment in Viridian Therapeutics, Inc. (NASDAQ:VRDN)
3/25/2025 - MarketBeat
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Sold by Yiheng Capital Management L.P.
3/22/2025 - MarketBeat
Viridian Therapeutics (VRDN, $15.32) Stochastic Oscillator left the oversold zone on March 20, 2025
3/21/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $15.32) entered Downtrend as Momentum indicator drops below 0 level on Mar 20, 2025
3/21/2025 - Tickeron - Stocks
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from Analysts
3/20/2025 - MarketBeat
Viridian Therapeutics (VRDN, $15.14) entered Downtrend as Momentum indicator drops below 0 level on Mar 18, 2025
3/19/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $15.81) Aroon Indicator entered a Downtrend on March 13, 2025.
3/14/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $16.65) Aroon Indicator entered a Downtrend on March 12, 2025.
3/13/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $16.09) Aroon Indicator entered a Downtrend on March 11, 2025.
3/12/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $15.58) Aroon Indicator entered a Downtrend on March 10, 2025.
3/11/2025 - Tickeron - Stocks
Viridian Therapeutics (VRDN, $15.58) Aroon Indicator entered a Downtrend on March 10, 2025.
3/11/2025 - Tickeron - Stocks
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/10/2025 - GuruFocus
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/10/2025 - Business Wire
Viridian Therapeutics (VRDN, $15.94) Aroon Indicator entered a Downtrend on March 07, 2025.
3/8/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$302.00K
EBITDA (TTM)
-$298.50M
EBIT (TTM)
-$299.04M
Net Income (TTM)
-$269.95M
Balance Sheet
Total Assets (Q)
$742.40M
Total Debt (Q)
$23.12M
Total Liabilities (Q)
$70.76M
Book Value Per Share (Q)
$5.96
Cash Flow
Cash from Operations (TTM)
-$232.32M
Cash from Investing (TTM)
-$228.65M
Cash from Financing (TTM)
$457.74M
Net Change in Cash (TTM)
-$3.23M
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.20
7-Day Total Return
-17.87%
30-Day Total Return
-28.52%
60-Day Total Return
-44.38%
90-Day Total Return
-40.72%
Year to Date Total Return
-41.14%
1-Year Total Return
-28.74%
2-Year Total Return
-53.98%
3-Year Total Return
-38.53%
5-Year Total Return
92.44%
52-week Low
Jun 04, 2024 - $11.40
52-week High
Nov 12, 2024 - $27.20
Valuation
Market Cap
$1.03B - Small Cap
Enterprise Value
$525.20M
Price/Sales (TTM)
3,418.92
Price/Book (Q)
2.12
Dividends and Shares
Shares Outstanding
80.05M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.viridiantherapeutics.com
Phone Number
617 272 4600
Address
221 Crescent Street
Waltham, MA 02453
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company’s product pipeline includes veligrotug, a monoclonal... more
NASDAQ 04/04/2025 12:37PM Eastern Quotes delayed
Weiss Ratings